What is the appropriate intrapartum antibiotic prophylaxis for a pregnant woman with a positive Group B Streptococcus vaginal culture?

Group B Strep Positive Vaginal Culture Treatment

For a pregnant woman with a positive Group B Streptococcus vaginal culture, administer intravenous penicillin G (5 million units initial dose, then 2.5-3.0 million units every 4 hours) or ampicillin (2 g initial dose, then 1 g every 4 hours) during labor until delivery. 1

First-Line Treatment Algorithm

For Non-Penicillin Allergic Patients:

• Penicillin G: 5 million units IV loading dose, followed by 2.5-3.0 million units IV every 4 hours until delivery 1
  • OR
• Ampicillin: 2 g IV loading dose, followed by 1 g IV every 4 hours until delivery 1

Both regimens are equally effective and achieve therapeutic levels in fetal circulation and amniotic fluid rapidly. The choice between them is typically based on institutional availability.

Penicillin-Allergic Patients

Low Risk for Anaphylaxis (No history of anaphylaxis, angioedema, respiratory distress, or urticaria):

• Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1

High Risk for Anaphylaxis:

The treatment depends on susceptibility testing:

• If GBS isolate is susceptible to both clindamycin AND erythromycin:

  • Clindamycin: 900 mg IV every 8 hours until delivery 1

• If susceptibility unknown OR isolate resistant to either clindamycin or erythromycin:

  • Vancomycin: 1 g IV every 12 hours until delivery 1

Important caveat: Erythromycin resistance often indicates inducible clindamycin resistance, even if the isolate appears susceptible to clindamycin. Only use clindamycin if testing confirms no inducible resistance. 1

Critical Timing Considerations

Optimal prophylaxis requires at least 4 hours of antibiotic administration before delivery to achieve maximum effectiveness in preventing early-onset neonatal GBS disease. 1, 2 However, this is a goal, not an absolute requirement:

• Even 2 hours of antibiotic exposure reduces GBS vaginal colony counts and decreases neonatal sepsis risk 3
• Do not delay medically necessary obstetric procedures solely to achieve 4 hours of prophylaxis 1
• Start antibiotics as soon as labor begins or membranes rupture in GBS-positive women

Updated Screening Window

The most recent ACOG guidelines (2020) recommend universal GBS screening between 36 0/7 and 37 6/7 weeks of gestation rather than the older 35-37 week window. 3, 4 This updated timing improves the accuracy of identifying colonization status at delivery.

Special Situations

Planned Cesarean Delivery:

• No IAP needed if cesarean is performed before labor onset with intact membranes 3, 5

Preterm Labor or Preterm Premature Rupture of Membranes:

• Screen for GBS at admission if no culture within preceding 5 weeks
• Start prophylaxis immediately
• If not in true labor, discontinue prophylaxis 1

Previous GBS Bacteriuria or Previous Infant with GBS Disease:

• Automatic indication for IAP; no screening needed 3, 5

Common Pitfalls to Avoid

1. Don't treat GBS colonization during pregnancy with oral antibiotics - this does not prevent neonatal disease and only promotes resistance. Treatment must be intrapartum. 1

2. Don't use erythromycin - it is no longer acceptable due to increasing resistance 1, 6

3. Don't assume negative screening remains valid indefinitely - GBS screening is only valid for 5 weeks 1

4. Don't withhold cefazolin from low-risk penicillin-allergic patients - it achieves effective intraamniotic concentrations and is preferred over vancomycin/clindamycin for this group 1

5. Don't delay necessary obstetric interventions to achieve the 4-hour threshold - some protection is better than none 3

The evidence strongly supports this universal screening and intrapartum prophylaxis approach, which has dramatically reduced early-onset GBS disease incidence from historical rates. The CDC 2010 guidelines 1 remain the foundation, with ACOG 2020 updates 3 refining the screening window based on more recent data.